May 2, 2018

United States Securities and Exchange Commission 

Division of Corporate Finance 

100 F Street, N.E. 

Washington, D.C. 20549 

Attention: Ms. Ada D. Sarmento
Ms. Erin Jaskot 

Re: InflaRx N.V.
Registration Statement on Form F-1 (SEC File No. 333-224596)

Dear Ms. Sarmento and Ms. Jaskot:

In connection with the above-referenced Registration Statement, and pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Act”), we hereby join in the request of InflaRx N.V. that the effective date of the Registration Statement be accelerated so that it will be declared effective at 4:00 p.m., Eastern time, on May 3, 2018 or as soon thereafter as practicable.

Pursuant to Rule 460 under the Act, please be advised that we have distributed 1,020 copies of the Preliminary Prospectus dated May 2, 2018 (the “Preliminary Prospectus”) through the date hereof, to underwriters, dealers, institutions and others.

(Signature page follows)

J.P. MORGAN SECURITIES LLC  

LEERINK PARTNERS LLC  

BMO CAPITAL MARKETS CORP.  

For themselves and as representatives of the syndicate of 

underwriters for the offering

J.P. MORGAN SECURITIES LLC

By:	/s/ David Ke
	Authorized Signatory

LEERINK PARTNERS LLC

By:	/s/ Jack Fitzgerald
	Authorized Signatory

BMO CAPITAL MARKETS CORP.

By:	/s/ Mihir Mantri
	Authorized Signatory